Please enable JavaScript in your web browser settings, under the site permissions section to unlock full site functionality. Click here for help.

Article Image - OPKO Health Acquires EirGen Pharma

Posted 28th May 2015

OPKO Health Acquires EirGen Pharma

OPKO Health Acquires EirGen Pharma

Scroll to keep reading

OPKO Health Acquires EirGen Pharma

OPKO Health Acquires EirGen Pharma

View Biography

Paul Heffernan, Legal Adviser OPKO Health

OPKO Health, Inc. is pleased to announce the acquisition of EirGen Pharma, Ltd., a growing, profitable and cash flow positive specialty pharmaceutical company focused on the development and commercial supply of high potency, high barrier to entry, pharmaceutical products for sale in the U.S., Canada, Japan, Australia, most European countries, and more than 40 others around the world.

EirGen, based in Waterford, Ireland, was founded by two former executives of IVAX Pharmaceuticals, Tom Brennan and Patsy Carney. The company, situated in a state of the art high containment research and development, and manufacturing facility, is approved by the FDA, EMEA (European Health Authorities) and the PMDA (Japanese Health Authorities). High potency drugs such as those used for cancer chemotherapy are typically unsuitable for manufacture in normal multi-product facilities due to cross contamination risks.

To date, EirGen and its commercial partners have filed 10 product applications with the FDA and 5 each in Europe and Japan. EirGen has a strong research and development portfolio of over 20 niche, high barrier to entry drugs and, with access to additional capital that OPKO will provide, together with the benefits of Irish government programs to encourage research and development in Ireland, EirGen will rapidly expand its drug portfolio.

“EirGen Pharma is one of the leading developers and suppliers of high potency niche pharmaceutical products in the world,” said Phillip Frost, M.D. OPKO’s Chairman and CEO. “As FineTech, OPKO’s Israeli active pharmaceutical ingredient manufacturing subsidiary, is also focused on high potency drugs, an immediate business synergy is expected. EirGen also offers the significant benefit of potentially being able to manufacture OPKO’s current and future products in our own facilities, which we expect will result in even higher gross margins. The superb management, research and development, manufacturing and product distribution teams, along with state of the art facilities, together, will create an important, tax efficient base of operations for OPKO,” said Dr. Frost.

Categories: M&A, Strategy

You Might Also Like

Procam’s Acquisition of HotCam

28/05/2015Procam’s Acquisition of HotCam

Procam's Acquisition of HotCam

LANDESK Finalizes AppSense Acquisition, Advances Lead in Unified Endpoint Management with Extended U

19/04/2016LANDESK Finalizes AppSense Acquisition, Advances Lead in Unified Endpoint Management with Extended U

LANDESK today announced it has completed the acquisition of California-based AppSense, the leading provider of secure user environment management solutions.

Overlooked Employee Issues When Acquiring a New Company

06/12/2021Overlooked Employee Issues When Acquiring a New Company

Overlooked Employee Issues When Acquiring a New Company Following the acquisition of a new company, there are tons of things that managers and human resources need to think about and do. In turn, that can mean many employee issues become overlooked. Don’t fo

Zedra Continues Growth Plans with Acquisition of Netherlands-Based Allied Corporate Services

04/07/2016Zedra Continues Growth Plans with Acquisition of Netherlands-Based Allied Corporate Services

ZEDRA (the “Group”), the global independent specialist in trust, fiduciary, corporate and fund services, announces that it has agreed the acquisition of Netherlands-based Allied Corporate Services (“Allied”).

Intelligent proliferation: Using AI effectively

26/04/2021Intelligent proliferation: Using AI effectively

Nate Burke, CEO of Diginius, a UK provider of proprietary software for digital marketing and ecommerce solutions, believes businesses could be getting more out of their use of AI. In this piece, he explains how businesses can use intelligent proliferation to t

Leader in Research and Development – North Wales

27/09/2022Leader in Research and Development – North Wales

We’ve all experienced a bad smell at some point in our lives, whether it’s from pets, children, leaky sewerage, or other people’s food in the office.

The Impact of Courier Services on E-commerce Businesses

03/07/2023The Impact of Courier Services on E-commerce Businesses

In this digital era we’re all living in, e-commerce has truly shaken up the way businesses function, offering ease and accessibility to folks all around the globe. The success of any e-commerce venture largely depends on a trusty and proficient courier s

Know Your Risk: Why Risk Management Has Never Been More Critical

27/01/2025Know Your Risk: Why Risk Management Has Never Been More Critical

In today’s fast-paced business environment, risk management has never been more critical, or more complex.

Can I Sign Documents Remotely While Self-Isolating?

17/03/2020Can I Sign Documents Remotely While Self-Isolating?

With many businesses reviewing business continuity policies in light of COVID-19, Jonathan Askin, corporate and commercial partner at JMW Solicitors, thought it might be helpful to set out to how e-signatures work so that this can be built into planning proced

View More Articles

Our Trusted Brands

Acquisition International is a flagship brand of AI Global Media. AI Global Media is a B2B enterprise and are committed to creating engaging content allowing businesses to market their services to a larger global audience. We have a number of unique brands, each of which serves a specific industry or region. Each brand covers the latest news in its sector and publishes a digital magazine and newsletter which is read by a global audience.

MORE BRANDS